Bile acid metabolism and signaling, the microbiota, and metabolic disease

J Cai, B Rimal, C Jiang, JYL Chiang… - Pharmacology & …, 2022 - Elsevier
The diversity, composition, and function of the bacterial community inhabiting the human
gastrointestinal tract contributes to host health through its role in producing energy or …

[HTML][HTML] Microbiome-based interventions to modulate gut ecology and the immune system

TCA Hitch, LJ Hall, SK Walsh, GE Leventhal, E Slack… - Mucosal …, 2022 - Elsevier
The gut microbiome lies at the intersection between the environment and the host, with the
ability to modify host responses to disease-relevant exposures and stimuli. This is evident in …

Gut microbiota-derived ursodeoxycholic acid from neonatal dairy calves improves intestinal homeostasis and colitis to attenuate extended-spectrum β-lactamase …

Z He, Y Ma, S Yang, S Zhang, S Liu, J **ao, Y Wang… - Microbiome, 2022 - Springer
Background Antimicrobials are often used to prevent and treat diarrhea induced by
enteroaggregative Escherichia coli (EAEC) in young ruminants. However, drug overuse or …

Recipient factors in faecal microbiota transplantation: one stool does not fit all

C Danne, N Rolhion, H Sokol - Nature Reviews Gastroenterology & …, 2021 - nature.com
Faecal microbiota transplantation (FMT) is a promising therapy for chronic diseases
associated with gut microbiota alterations. FMT cures 90% of recurrent Clostridioides difficile …

Capturing the environment of the Clostridioides difficile infection cycle

MK Schnizlein, VB Young - Nature Reviews Gastroenterology & …, 2022 - nature.com
Clostridioides difficile (formerly Clostridium difficile) infection is a substantial health and
economic burden worldwide. Great strides have been made over the past several years in …

The pathophysiology of farnesoid X receptor (FXR) in the GI tract: inflammation, barrier function and innate immunity

KM Anderson, CP Gayer - Cells, 2021 - mdpi.com
The Farnesoid-X Receptor, FXR, is a nuclear bile acid receptor. Its originally described
function is in bile acid synthesis and regulation within the liver. More recently, however, FXR …

Bile acids impact the microbiota, host, and C. difficile dynamics providing insight into mechanisms of efficacy of FMTs and microbiota-focused therapeutics

AS McMillan, CM Theriot - Gut Microbes, 2024 - Taylor & Francis
Clostridioides difficile is a major nosocomial pathogen, causing significant morbidity and
mortality worldwide. Antibiotic usage, a major risk factor for Clostridioides difficile infection …

Targeting gut microbial bile salt hydrolase (BSH) by diet supplements: new insights into dietary modulation of human health

Y Yang, C Wu - Food & Function, 2022 - pubs.rsc.org
The gut microbiome is increasingly recognized as a vital organ that participates in nutrient
acquisition, energy regulation and maintenance of human health. Targeted manipulation of …

Gut associated metabolites and their roles in Clostridioides difficile pathogenesis

AM Aguirre, JA Sorg - Gut Microbes, 2022 - Taylor & Francis
The nosocomial pathogen Clostridioides difficile is a burden to the healthcare system. Gut
microbiome disruption, most commonly by broad-spectrum antibiotic treatment, is well …

Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut …

L Martinez-Gili, JK McDonald, Z Liu, D Kao… - Gut …, 2020 - Taylor & Francis
Fecal microbiota transplant (FMT) is a highly-effective therapy for recurrent Clostridioides
difficile infection (rCDI), and shows promise for certain non-CDI indications. However, at …